Waldenström's macroglobulinemia bone marrow aspiration and biopsy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
Findings suggestive of Waldenström macroglobulinemia include:<ref name="pmid18555588">{{cite journal| author=Leleu X, Roccaro AM, Moreau AS, Dupire S, Robu D, Gay J et al.| title=Waldenstrom macroglobulinemia. | journal=Cancer Lett | year= 2008 | volume= 270 | issue= 1 | pages= 95-107 | pmid=18555588 | doi=10.1016/j.canlet.2008.04.040 | pmc=3133633 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18555588  }} </ref>
Findings suggestive of Waldenström macroglobulinemia include:<ref name="pmid18555588">{{cite journal| author=Leleu X, Roccaro AM, Moreau AS, Dupire S, Robu D, Gay J et al.| title=Waldenstrom macroglobulinemia. | journal=Cancer Lett | year= 2008 | volume= 270 | issue= 1 | pages= 95-107 | pmid=18555588 | doi=10.1016/j.canlet.2008.04.040 | pmc=3133633 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18555588  }} </ref>
* A hypercellular bone marrow aspirate.
* A hypercellular bone marrow aspirate.
* Lymphoplasmacytic infiltrate with characteristic immunophenotype.
* Lymphoplasmacytic infiltrate with characteristic [[immunophenotype]].


{|
{|
Line 24: Line 24:
* Hypercellular and [[Infiltration (medical)|infiltrated]] with [[lymphoid]] and [[Plasmacytoid|plasmacytoid cells]].
* Hypercellular and [[Infiltration (medical)|infiltrated]] with [[lymphoid]] and [[Plasmacytoid|plasmacytoid cells]].


* Dutcher bodies (PAS positive intra-nuclear vacuoles containing IgM monoclonal protein).  
* Dutcher bodies (PAS positive intra-nuclear vacuoles containing [[IgM]] monoclonal protein).  
** Characteristic feature of Waldenström macroglobulinemia.
** Characteristic feature of Waldenström macroglobulinemia.
Three patterns of marrow involvement are described, as follows:
Three patterns of marrow involvement are described, as follows:
* Lymphoplasmacytoid cells (lymphoplasmacytic and small lymphocytes) in a nodular pattern.
* Lymphoplasmacytoid cells ([[Lymphoplasmacytic lymphoma|lymphoplasmacytic]] and small lymphocytes) in a nodular pattern.
* Lymphoplasmacytic cells (small lymphocytes, mature plasma cells, mast cells) in an interstitial/nodular pattern.
* Lymphoplasmacytic cells (small lymphocytes, mature plasma cells, mast cells) in an interstitial/nodular pattern.
* A polymorphous infiltrate (small lymphocytes, plasma cells, plasmacytoid cells, immunoblasts with mitotic figures).
* A polymorphous infiltrate (small lymphocytes, plasma cells, plasmacytoid cells, immunoblasts with mitotic figures).

Revision as of 18:31, 8 April 2019

Waldenström's macroglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Waldenström's macroglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Bone Marrow Aspiration and Biopsy

Electrophoresis and Immunofixation

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Waldenström's macroglobulinemia bone marrow aspiration and biopsy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Waldenström's macroglobulinemia bone marrow aspiration and biopsy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Waldenström's macroglobulinemia bone marrow aspiration and biopsy

CDC on Waldenström's macroglobulinemia bone marrow aspiration and biopsy

Waldenström's macroglobulinemia bone marrow aspiration and biopsy in the news

Blogs on Waldenström's macroglobulinemia bone marrow aspiration and biopsy

Directions to Hospitals Treating Waldenström's macroglobulinemia

Risk calculators and risk factors for Waldenström's macroglobulinemia bone marrow aspiration and biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Roukoz A. Karam, M.D.[3]

Overview

A bone marrow aspiration is essential in the diagnosis of Waldenström macroglobulinemia.

Bone Marrow Aspirate

A bone marrow aspirate is essential in the diagnosis of Waldenström macroglobulinemia.

Findings suggestive of Waldenström macroglobulinemia include:[1]

  • A hypercellular bone marrow aspirate.
  • Lymphoplasmacytic infiltrate with characteristic immunophenotype.
Bone marrow aspirate. Lymphocytes with lymphoplasmacytoid appearance (arrows).Source: D'Angelo G. et al, Laboratorio di Chimica-Clinica, Ematologia e Microbiologia (Ematologia/Coagulazione), Azienda Ospedaliera "S. Antonio Abate" di Gallarate, Varese, Italy.

Bone Marrow Biopsy

A bone marrow biopsy may be helpful in the diagnosis of Waldenström macroglobulinemia. [1]

Findings on the biopsy suggestive of Waldenström macroglobulinemia include:[1]

  • Dutcher bodies (PAS positive intra-nuclear vacuoles containing IgM monoclonal protein).
    • Characteristic feature of Waldenström macroglobulinemia.

Three patterns of marrow involvement are described, as follows:

  • Lymphoplasmacytoid cells (lymphoplasmacytic and small lymphocytes) in a nodular pattern.
  • Lymphoplasmacytic cells (small lymphocytes, mature plasma cells, mast cells) in an interstitial/nodular pattern.
  • A polymorphous infiltrate (small lymphocytes, plasma cells, plasmacytoid cells, immunoblasts with mitotic figures).

References

  1. 1.0 1.1 1.2 Leleu X, Roccaro AM, Moreau AS, Dupire S, Robu D, Gay J; et al. (2008). "Waldenstrom macroglobulinemia". Cancer Lett. 270 (1): 95–107. doi:10.1016/j.canlet.2008.04.040. PMC 3133633. PMID 18555588.

Template:WH Template:WS